Sign Up Today and Learn More About Cambridge Epigenetix Stock
Invest in or calculate the value of your shares in Cambridge Epigenetix or other pre-IPO companies through EquityZen's platform.
Cambridge Epigenetix Stock (CAEI)
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
About Cambridge Epigenetix Stock
Founded
2012
Industries
Science and Engineering, Health Care, Biotechnology
Cambridge Epigenetix Press Mentions
Stay in the know about the latest news on Cambridge Epigenetix
Methods for analyzing nucleic acids
patents • Apr 14, 2024
People in the News at Quantum-Si, Cambridge Epigenetix, Sema4, More
genomeweb • Jun 18, 2022
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
globenewswire • Jun 14, 2022
Last Year Was A Blockbuster For VC-Backed Startups. Here Are Our Top 9 Predictions For What 2022 Has In Store
news • Jan 07, 2022
For 2022, Here’s What Startups Are Doing To Extend Our Lifespans
news • Jan 05, 2022
Cambridge Epigenetix Management
Leadership team at Cambridge Epigenetix
Co-Founder and Director
Shankar Balasubramian
Co-Founder and Director
Bobby Yerramilli-Rao
Join now and verify your accreditation status to gain access to:
- Cambridge Epigenetix current valuation
- Cambridge Epigenetix stock price
- Available deals in Cambridge Epigenetix and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cambridge Epigenetix stock?
Accredited investors can buy pre-IPO stock in companies like Cambridge Epigenetix through EquityZen funds. These investments are made available by existing Cambridge Epigenetix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cambridge Epigenetix stock?
Shareholders can sell their Cambridge Epigenetix stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
